Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webca

Go back to Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webca
(NASDAQ: MDCX) Delayed: 0.43 --0 (-0%)
Previous Close $0.43    52 Week High
Open $0.43    52 Week Low
Day High $0.43    P/E N/A 
Day Low $0.43    EPS
Volume 13,163       

(NASDAQ: MDCX) Delayed: 0.43 --0 (-0%)
Previous Close $0.43    52 Week High
Open $0.43    52 Week Low
Day High $0.43    P/E N/A 
Day Low $0.43    EPS
Volume 13,163